GL1X · GenesisL1 explorer

MolNFT v1 · #10576 · protein

The crystallographic structure of the protease from human immunodeficiency virus type 2 with two synthetic peptidic transition state analog inhibitors

1IVP · HIV-2 protease: “The crystallographic structure of the protease from human immunodeficiency virus type 2 with two synthetic…”. X-ray diffraction, 1 ligand (1ZK), 1 pocket (best druggability 0.70). MolNFT v1 #10576 on GenesisL1: 3D…

PDB
1IVP
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-2 protease
UniProt
P04584
Ligands
1ZK
Pockets
1 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 54% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BHIV-2 proteaseprotein997% helix, 54% strandP04584

Ligands and binding sites

  • 1ZK · 4-[(2R)-3-{[(1S,2S,3R,4S)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methyl-4-({(1S,2R)-2-methyl-1-[(pyridin-2-ylmethyl)carba moyl]butyl}carbamoyl)hexyl]amino}-2-{[(naphthalen-1-yloxy)acetyl]amino}-3-oxopropyl]-1H-imidazol-3-ium · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14020.700.82351ZK

Interfaces

1 interface between chains.

  • A–B · 1742 Ų buried · 32 hydrogen bonds · protein-protein

Compared structures

  • 1IVP · The crystallographic structure of the protease from human immunodeficiency virus type 2… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.